The Effects of Estrogen, Progesterone, and C-erbB-2 Receptor States on ^sup 18^F-FDG Uptake of Primary Breast Cancer Lesions

The purpose of this prospective study was to investigate whether correlations exist between 18F-FDG uptake of primary breast cancer lesions and predictive and prognostic factors such as estrogen receptor (ER), progesterone receptor (PR), and C-erbB-2 receptor (C-erbB-2R) states. Methods: Before unde...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of nuclear medicine (1978) Vol. 48; no. 8; p. 1266
Main Authors Mavi, Ayse, Cermik, Tevfik F, Urhan, Muammer, Puskulcu, Halis
Format Journal Article
LanguageEnglish
Published New York Society of Nuclear Medicine 01.08.2007
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The purpose of this prospective study was to investigate whether correlations exist between 18F-FDG uptake of primary breast cancer lesions and predictive and prognostic factors such as estrogen receptor (ER), progesterone receptor (PR), and C-erbB-2 receptor (C-erbB-2R) states. Methods: Before undergoing partial or total mastectomy, 213 patients with newly diagnosed breast cancer underwent 18F-FDG PET (5.2 MBq/kg of body weight). The maximum standardized uptake value (SUV) of the primary lesion was measured in each patient. Standard immunohistochemistry was performed on a surgical specimen of the cancer lesion to characterize the receptor state of the tumor cells. Pearson X2 tests were performed on the cross-tables of different receptor states to test any association that may exist among ER, PR, and C-erbB-2R. Maximum SUV measurements for different receptor states were compared using factorial ANOVA in a completely random design. Results: After exclusion of certain lesions, 118 lesions were analyzed for this study. The mean maximum SUVs of ER-positive and ER-negative lesions were 3.03 ± 0.26 and 5.64 ± 0.75, whereas those of PR were 3.24 ± 0.29 and 4.89 ± 0.67, respectively, and those of C-erbB-2R were 4.64 ± 0.70 and 3.70 ± 0.35, respectively, x2 tests for ER and PR showed that if one is positive then the other tends to be positive as well (x2 = 71.054,P< 0.01). For ER and C-erbB-2R states, if ER is positive, C-erbB-2R will more likely be negative (x2 = 13.026, P < 0.01 ). No relationship was detected between PR and C-erbB-2R states (?2 = 3.695, P > 0.05). ANOVAs showed that PR state atañe (F = 0.095, P > 0.05) and C-erbB-2R state alone (F = 0.097, P > 0.05) had no effect on 18F-FDG uptake but ER state alone had an effect (F = 9.126, P < 0.01). ER and PR being together had no additional effect on 18FFDG uptake. Our study also demonstrated that interactions exist between ER and C-erbB-2R state and between PR and C-erbB2R state. Conclusion: SUV measurements may provide valuable information about the state of ER, PR, and C-erbB-2R and the associated glucose metabolism as measured by 18F-FDG uptake of the primary breast cancer lesions. Such an association may be of importance to treatment planning and outcome in these patients. [PUBLICATION ABSTRACT]
AbstractList The purpose of this prospective study was to investigate whether correlations exist between 18F-FDG uptake of primary breast cancer lesions and predictive and prognostic factors such as estrogen receptor (ER), progesterone receptor (PR), and C-erbB-2 receptor (C-erbB-2R) states. Methods: Before undergoing partial or total mastectomy, 213 patients with newly diagnosed breast cancer underwent 18F-FDG PET (5.2 MBq/kg of body weight). The maximum standardized uptake value (SUV) of the primary lesion was measured in each patient. Standard immunohistochemistry was performed on a surgical specimen of the cancer lesion to characterize the receptor state of the tumor cells. Pearson X2 tests were performed on the cross-tables of different receptor states to test any association that may exist among ER, PR, and C-erbB-2R. Maximum SUV measurements for different receptor states were compared using factorial ANOVA in a completely random design. Results: After exclusion of certain lesions, 118 lesions were analyzed for this study. The mean maximum SUVs of ER-positive and ER-negative lesions were 3.03 ± 0.26 and 5.64 ± 0.75, whereas those of PR were 3.24 ± 0.29 and 4.89 ± 0.67, respectively, and those of C-erbB-2R were 4.64 ± 0.70 and 3.70 ± 0.35, respectively, x2 tests for ER and PR showed that if one is positive then the other tends to be positive as well (x2 = 71.054,P< 0.01). For ER and C-erbB-2R states, if ER is positive, C-erbB-2R will more likely be negative (x2 = 13.026, P < 0.01 ). No relationship was detected between PR and C-erbB-2R states (?2 = 3.695, P > 0.05). ANOVAs showed that PR state atañe (F = 0.095, P > 0.05) and C-erbB-2R state alone (F = 0.097, P > 0.05) had no effect on 18F-FDG uptake but ER state alone had an effect (F = 9.126, P < 0.01). ER and PR being together had no additional effect on 18FFDG uptake. Our study also demonstrated that interactions exist between ER and C-erbB-2R state and between PR and C-erbB2R state. Conclusion: SUV measurements may provide valuable information about the state of ER, PR, and C-erbB-2R and the associated glucose metabolism as measured by 18F-FDG uptake of the primary breast cancer lesions. Such an association may be of importance to treatment planning and outcome in these patients. [PUBLICATION ABSTRACT]
Author Mavi, Ayse
Cermik, Tevfik F
Urhan, Muammer
Puskulcu, Halis
Author_xml – sequence: 1
  givenname: Ayse
  surname: Mavi
  fullname: Mavi, Ayse
– sequence: 2
  givenname: Tevfik
  surname: Cermik
  middlename: F
  fullname: Cermik, Tevfik F
– sequence: 3
  givenname: Muammer
  surname: Urhan
  fullname: Urhan, Muammer
– sequence: 4
  givenname: Halis
  surname: Puskulcu
  fullname: Puskulcu, Halis
BookMark eNqNjc1uwjAQhC0EUgP0HVY9Y8kOOIQrISkHDoifK8hNNy1Q7LDrHJD68ASpD9DTd5iZb_qi67zDjoi0GRtpkmTaFZHSiZbGKPMi-sxnpVSSpmkkfnffCHlVYRkYfAU5B_Jf6EawfpIDUisbgXWfkEmkj7mMYYMl1sETbIMN2O4cHLipQaeHQhaLd9jXwV7w6VvT6WrpDnNCywEy60okWCGfvOOh6FX2h_H1jwPxVuS7bClr8remPT-efUOujY6xnsWTyWxqxv8qPQBfgE7w
CODEN JNMEAQ
ContentType Journal Article
Copyright Copyright Society of Nuclear Medicine Aug 2007
Copyright_xml – notice: Copyright Society of Nuclear Medicine Aug 2007
DBID 3V.
4T-
7RV
7X7
7XB
88E
88I
8AF
8AO
8FD
8FE
8FG
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
ARAPS
AZQEC
BBNVY
BENPR
BGLVJ
BHPHI
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
KB0
LK8
M0S
M1P
M2P
M7P
M7Z
NAPCQ
P5Z
P62
P64
PQEST
PQQKQ
PQUKI
Q9U
S0X
DatabaseName ProQuest Central (Corporate)
Docstoc
Nursing & Allied Health Database
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Science Database (Alumni Edition)
STEM Database
ProQuest Pharma Collection
Technology Research Database
ProQuest SciTech Collection
ProQuest Technology Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Technology Collection
Natural Science Collection
ProQuest One Community College
ProQuest Central
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection (Proquest) (PQ_SDU_P3)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Biological Sciences
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Science Database
Biological Science Database
Biochemistry Abstracts 1
Nursing & Allied Health Premium
Advanced Technologies & Aerospace Database
ProQuest Advanced Technologies & Aerospace Collection
Biotechnology and BioEngineering Abstracts
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central Basic
SIRS Editorial
DatabaseTitle ProQuest Central Student
Technology Collection
Technology Research Database
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
SIRS Editorial
ProQuest Health & Medical Complete (Alumni)
ProQuest AP Science
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
ProQuest Medical Library (Alumni)
Advanced Technologies & Aerospace Collection
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Advanced Technologies & Aerospace Database
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Docstoc
Biochemistry Abstracts 1
ProQuest Nursing & Allied Health Source (Alumni)
Engineering Research Database
ProQuest One Academic
ProQuest Central (Alumni)
DatabaseTitleList ProQuest Central Student
Database_xml – sequence: 1
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1535-5667
ExternalDocumentID 1322000381
GroupedDBID ---
-~X
.55
.GJ
29L
2WC
3V.
4T-
53G
5RE
7RV
7X7
7XB
88E
88I
8AF
8AO
8FD
8FE
8FG
8FH
8FI
8FJ
8FK
8R4
8R5
8WZ
A6W
ABSQV
ABUWG
ACGOD
ACIWK
ACPRK
ADDZX
AENEX
AFFNX
AFKRA
AFOSN
AFRAH
AHMBA
AI.
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ARAPS
AZQEC
BBNVY
BENPR
BGLVJ
BHPHI
BKEYQ
BPHCQ
BVXVI
CCPQU
CS3
DIK
DU5
DWQXO
E3Z
EBS
EJD
EMOBN
EX3
F5P
F9R
FR3
FYUFA
GNUQQ
H13
HCIFZ
HMCUK
I-F
IL9
INIJC
K9.
KQ8
L7B
LK8
M1P
M2P
M2Q
M7P
M7Z
N4W
NAPCQ
OK1
P2P
P62
P64
PQEST
PQQKQ
PQUKI
PROAC
PSQYO
Q2X
Q9U
R0Z
RHF
RHI
RNS
RWL
S0X
SJN
SV3
TAE
TR2
TSM
UKHRP
VH1
W8F
WH7
WOQ
WOW
X7M
YHG
ID FETCH-proquest_journals_2192449753
IEDL.DBID BENPR
ISSN 0161-5505
IngestDate Thu Oct 10 22:40:19 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 8
Language English
LinkModel DirectLink
MergedId FETCHMERGED-proquest_journals_2192449753
PQID 219244975
PQPubID 40808
ParticipantIDs proquest_journals_219244975
PublicationCentury 2000
PublicationDate 20070801
PublicationDateYYYYMMDD 2007-08-01
PublicationDate_xml – month: 08
  year: 2007
  text: 20070801
  day: 01
PublicationDecade 2000
PublicationPlace New York
PublicationPlace_xml – name: New York
PublicationTitle The Journal of nuclear medicine (1978)
PublicationYear 2007
Publisher Society of Nuclear Medicine
Publisher_xml – name: Society of Nuclear Medicine
SSID ssj0006888
Score 3.7719665
Snippet The purpose of this prospective study was to investigate whether correlations exist between 18F-FDG uptake of primary breast cancer lesions and predictive and...
SourceID proquest
SourceType Aggregation Database
StartPage 1266
SubjectTerms Biopsy
Breast cancer
Health Insurance Portability & Accountability Act 1996-US
Health services
Medical treatment
Metabolism
Patients
Progesterone
Studies
Tissues
Tumors
Title The Effects of Estrogen, Progesterone, and C-erbB-2 Receptor States on ^sup 18^F-FDG Uptake of Primary Breast Cancer Lesions
URI https://www.proquest.com/docview/219244975
Volume 48
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fa8IwED6mwtjL2E-2uckx9mhYW1PbPo3pWmVMkTHBJyVZ0xeh7Wx92x-_XBt9GfiSPATCkS_cfXe53AE82X7MXUvGzO7ZCaNqIEwqKVjQ16MtFOcBfRSeTPvjOX9fuAuTm1OYtMqdTqwUdZx9U4z82SFPgQee-5L_MGoaRY-rpoNGA1qOdhSsJrQG4XT2uVfFfb9qPEm0hhEV_6dwKysSncGpoX_4WuN1DkcqvYDjiXngvoRfDRvWFYULzBIMi3KTaYy7OKOZqhpkqeqi9v9xyPSRDJiDmvqpXPvOWDNHzFJcFtscbX8ZsehthPO8FGtF-83q4hI4oFz0EoeE-QY_FMXMiit4jMKv4ZjtpF-Zm1as9ufSu4ZmqkW4AbSSxEo8xWNHSC57wtdik2kWtgyE78W30D6w0d3B1Tac1OFNyoG7h2a52aoHbZdL2YGGt_D06EejjkHiD0Yul2U
link.rule.ids 315,783,787,12068,12777,21400,31731,33385,33756,43322,43612,43817,74079,74369,74636
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV07T8MwED5BkYAF8RRQHifEWIs6cZtkQrQ0FGiqDq2UqZVNnAUpCU268ePxJWkXpC72YMk6-bPu5fN3AI_cjUSnrSLGbR4zYgNhSivJvK4ZudRCePRROBh3hzPxEXbCujYnr8sq1zqxVNRR-kU58ieLIgXhOZ3n7IdR0yh6XK07aOzCHtFwUQMDJ9zEW9ROxa2ovTkjR_yfui1tiH8MR7Xzhy8VWiewo5NT2A_q5-0z-DWgYcUnnGMa4yAvlqlBuIUTmonTIE10C030j31mDqTHLDSOn85M5IyV34hpgvN8lSF35z7zX99wlhXyW9N-k4paAntUiV5gnxBf4khTxiw_hwd_MO0P2Vr6RX3P8sXmVOwLaCRGhEvAdhy3Y0eLyJJKKFu6RmwyzJIrT7pOdAXNLRtdb129h4PhNBgtRu_jzyYcVolOqoa7gUaxXOlbY6ELdVfi8AfdO5cj
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV07T8MwED5BkSoWxFNAeZwQY602jZvHhOgjLdBWGajUqZVNnAUpCU268ePxJW4XpC7OYMk6-bPuPp8v3wE8W17Eu20ZMcu2YkZqIEwqKZjv6NESinOffhSezpzxnL8vugsjKZSbssqtTywddZR-UY681aGbAvfdbis2VRHhIHjJfhg1kKKHVtNN4xCOdFB06IB7wWjnlB2vbEFJBIcRKf_nest4EpzCiSGC-FohdwYHKjmH-tQ8dV_ArwYQK23hHNMYh3mxTjXaTQzpS_oGaaKaKJII-0xvTo91UJNAlelbNFYcEtMEl_kmQ8tbBiwYjHCeFeJb0XphJTOBPapKL7BP6K9xoih7ll_CUzD87I_Z1vqVOXP5ardD9hXUEm3CNWA7jtuxq3jUEZJLW3jabArSwpK-8NzoBhp7FrrdO_sIdQ3BavI2-2jAcZXzpMK4O6gV642618G6kA8lDH9K0Jth
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Effects+of+Estrogen%2C+Progesterone%2C+and+C-erbB-2+Receptor+States+on+%5Esup+18%5EF-FDG+Uptake+of+Primary+Breast+Cancer+Lesions&rft.jtitle=The+Journal+of+nuclear+medicine+%281978%29&rft.au=Mavi%2C+Ayse&rft.au=Cermik%2C+Tevfik+F&rft.au=Urhan%2C+Muammer&rft.au=Puskulcu%2C+Halis&rft.date=2007-08-01&rft.pub=Society+of+Nuclear+Medicine&rft.issn=0161-5505&rft.eissn=1535-5667&rft.volume=48&rft.issue=8&rft.spage=1266&rft.externalDBID=HAS_PDF_LINK&rft.externalDocID=1322000381
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0161-5505&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0161-5505&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0161-5505&client=summon